Essay Series · Four Parts · Complete
The Cardiac Borough
Can the production of cardiometabolic health replace the gravitational economic role Wall Street has played in New York City for a century?
Four Parts
Full Series Index
-
I
After the Anchor Industry Why cities that lose their anchor industry lose their story first — and what the Pittsburgh healthcare transformation teaches New York about the difference between receiving an economy and seizing one.
-
II
What Healthcare Wants The cardiometabolic market — GLP-1s, CGMs, fertility, dementia prevention — is not waiting to be created; it is already voting with out-of-pocket dollars against a system that has failed to meet it, and New York's hospital systems are not on the list of employers' preferred clinical partners.
-
III
The Enrollment Is the Platform New York's 745,000 union members — 32BJ SEIU, the building trades, municipal workers — represent the largest organized pool of healthcare purchasing power in the country and the most strategically positioned enrollment engine for a cardiometabolic data platform the world has not previously had.
-
IV
The Cardiometabolic Dividend The Albany tax fight is a symptom of a ghost framework — and the Cardiometabolic Dividend is the fiscal architecture that makes it a footnote: a data participation agreement through which New York captures equity in the commercial value its 8.3 million residents' biological records generate.